Ligand Pharmaceuticals (LGND)
Create an Alert
32.39
-0.15 -0.46%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Ligand Pharmaceuticals Interest Expense:
0.00 for March 31, 2013Ligand Pharmaceuticals Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.00 |
| Dec. 31, 2012 | 0.845M |
| Sept. 30, 2012 | 0.838M |
| June 30, 2012 | 0.847M |
| March 31, 2012 | 0.00 |
| Dec. 31, 2011 | 0.715M |
| Sept. 30, 2011 | 0.699M |
| June 30, 2011 | 0.674M |
| March 31, 2011 | 0.423M |
| Dec. 31, 2010 | -0.039M |
| Sept. 30, 2010 | 0.008M |
| June 30, 2010 | 0.013M |
| March 31, 2010 | 0.018M |
| Dec. 31, 2009 | 0.013M |
| Sept. 30, 2009 | 0.021M |
| June 30, 2009 | 0.042M |
| March 31, 2009 | 0.194M |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
LGND Interest Expense Benchmarks
| Companies | |
|---|---|
| Momenta Pharmaceuticals | 0.00 |
| NovaBay Pharmaceuticals | 0.00 |
| AVANIR Pharmaceuticals | 1.059M |
LGND Interest Expense Rankings
| Overall |
99th percentile 68 of 16782 |
| Sector |
99th percentile 8 of 1410 in Healthcare |
| Industry |
98th percentile 3 of 152 in Drug Manufacturers - Specialty & Generic |
LGND Interest Expense Range, Past 5 Years
| Minimum | -0.0390M | Dec 2010 |
| Maximum | 0.8470M | Jun 2012 |
| Average | 0.2655M |
